Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Esser

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Oral Oncology|December 3, 2014
Trends in epidemiology and treatment and outcome for head and neck cancer: a population-based long-term analysis from 1996 to 2011 of the Thuringian cancer registryOrlando Guntinas-Lichius, Thomas G Wendt, Nicole Kornetzky, et al.
International Journal of Pediatric Otorhinolaryngology|September 3, 2013
Pediatric adenoidectomy: a population-based regional study on epidemiology and outcomeKonstanze Thomas, Daniel Boeger, Jens Buentzel, et al.
Journal of Cancer Research and Clinical Oncology|March 25, 2015
Incidence, treatment, and outcome of parotid carcinoma, 1996-2011: a population-based study in Thuringia, GermanyOrlando Guntinas-Lichius, Thomas G Wendt, Jens Buentzel, et al.
Cancer Medicine|October 12, 2016
Role of comorbidity on outcome of head and neck cancer: a population-based study in Thuringia, GermanyIrene Göllnitz, Johanna Inhestern, Thomas G Wendt, et al.
Protein Science : a Publication of the Protein Society|August 24, 2004
Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coliJennifer White, Petra Lukacik, Dirk Esser, et al.
Blood|December 3, 2005
Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapyAnita Hill, Simon H Ridley, Dirk Esser, et al.
Gastroenterology|July 5, 2011
Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitisJean Frédéric Colombel, Paul Rutgeerts, Walter Reinisch, et al.
Cancer Research|April 9, 2009
Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-outHartmut P H Neumann, Zoran Erlic, Carsten C Boedeker, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Oral Oncology|December 3, 2014
Trends in epidemiology and treatment and outcome for head and neck cancer: a population-based long-term analysis from 1996 to 2011 of the Thuringian cancer registryOrlando Guntinas-Lichius, Thomas G Wendt, Nicole Kornetzky, et al.
International Journal of Pediatric Otorhinolaryngology|September 3, 2013
Pediatric adenoidectomy: a population-based regional study on epidemiology and outcomeKonstanze Thomas, Daniel Boeger, Jens Buentzel, et al.
Journal of Cancer Research and Clinical Oncology|March 25, 2015
Incidence, treatment, and outcome of parotid carcinoma, 1996-2011: a population-based study in Thuringia, GermanyOrlando Guntinas-Lichius, Thomas G Wendt, Jens Buentzel, et al.
Cancer Medicine|October 12, 2016
Role of comorbidity on outcome of head and neck cancer: a population-based study in Thuringia, GermanyIrene Göllnitz, Johanna Inhestern, Thomas G Wendt, et al.
Protein Science : a Publication of the Protein Society|August 24, 2004
Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coliJennifer White, Petra Lukacik, Dirk Esser, et al.
Blood|December 3, 2005
Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapyAnita Hill, Simon H Ridley, Dirk Esser, et al.
Gastroenterology|July 5, 2011
Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitisJean Frédéric Colombel, Paul Rutgeerts, Walter Reinisch, et al.
Cancer Research|April 9, 2009
Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-outHartmut P H Neumann, Zoran Erlic, Carsten C Boedeker, et al.
Pageof 4